British Journal of Dermatology · 1977 · 158 citations · 16 references
MedicineDermatologyPharmacotherapyAutoimmunityDermatopathologyImmunopathologyAutoantigensAutoimmune DiseasesAutoimmune Skin DiseasesImmunopathology Of SkinInflammatory Skin DiseasesPigmentary DisordersDermatologic Corticosteroid TherapyTopical Corticosteroid PharmacologyTopical Corticosteroid PreparationsTopical Dermatologic TherapyTreatment With Topical CorticosteroidsVitiligo PhototherapyVitiligo Treatment
Local injection of physostigmine revealed that dermatomally distributed vitiligo was associated with a dysfunction of the sympathetic nerves in the affected skin and that non-dermatomally distributed vitiligo was not. These observations led to the hypothesis that the primary disturbance of dermatomally distributed vitiligo lies in the sympathetic nerves of the affected area and that non-dermatomally distributed vitiligo has its primary disturbance in the melanocyte itself, where an autoimmune mechanism is suspect. Results of therapy supported this hypothesis by showing that topical cortisteroid is effective only in the latter, while the former reacts to oral nialamide. It is proposed that non-dermatomally distributed vitiligo be referred to as Type A and dermatomally distributed vitiligo as Type B.
16
Aaron B. Lerner · Journal of Investigative Dermatology · 1959 · 300 citations · Full text
VITILIGO, THYROID DISEASE AND AUTOIMMUNITY
W.J. Cunliffe, R. Hall, D. J. Newell et al. · British Journal of Dermatology · 1968 · 287 citations
Medicine, Dermatology, Endocrinology +14
Yukio Ochi · Annals of Internal Medicine · 1969 · 85 citations
Medicine, Dermatology, Endocrinology +12